Genmab A/S

GMABNasdaq Denmark Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$4.015 B

$31.25 +4.76%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#64Enliven TherapeuticsELVN$4.43B
#65Parabilis MedicinesPBLS$4.15B
#66Genmab A/SGMAB$4.01B
#67Viking TherapeuticsVKTX$4.00B
#68Tango TherapeuticsTNGX$3.92B

Where these numbers come from

Share counts and financials for Genmab A/S are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.